SCHEMBL3884588

SCHEMBL3884588

Cc1nc2c(O)cccc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 2/20 0.59
▸ KDM4E B2RXH2 1/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ MGAM O43451 6/20 0.50
▸ GAA P10253 6/20 0.50
▸ SI P14410 6/20 0.50
▸ MGAM2 Q2M2H8 6/20 0.50
▸ ADRB2 P07550 1/20 0.50
▸ GRIN1 Q05586 1/20 0.47
▸ GRIN2B Q13224 1/20 0.47
▸ METAP2 P50579 1/20 0.46
▸ COASY Q13057 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ DHODH Q02127 1/20 0.43
▸ PDE10A Q9Y233 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8014752 0.79 MGAM (0.43) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL4314003 0.79 ACHE (0.46) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL353891 0.79 PARP1 (0.56) PARP1MGAMGAASIMGAM2
SCHEMBL20936149 0.79 PARP1 (0.56) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL3237187 0.78 PARP1 (0.53) PARP1KDM4ECYP1A2CYP2D6CYP2C9
Bromide SCHEMBL11628987 0.78 ACHE (0.45) PARP1KDM4ECYP1A2CYP2D6CYP2C9
Bromide SCHEMBL5318091 0.78 PARP1 (0.55) PARP1MGAMGAASIMGAM2
SCHEMBL8263596 0.77 PARP1 (0.54) PARP1KDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL14222708 0.76 NUDT1 (0.51) MGAMGAASIMGAM2GRIN1
SCHEMBL6509697 0.76 ADRB2 (0.58) PARP1KDM4ECYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1002520-B1 Composition for oxidative dying of keratinous fibres and dying process therewith OREAL (FR) 2008-10-29 — — EP claimed
US-6893470-B1 Keratinous fibre oxidation dyeing composition containing a laccase and dyeing method using same L'OREAL S.A. (FR) 2005-05-17 — — US claimed
US-6890362-B2 Oxidation dyeing composition for keratinous fibers and dyeing method using same L'OREAL, S.A. (FR) 2005-05-10 — — US claimed
EP-0988021-B1 KERATIN FIBRE OXIDATION DYEING COMPOSITION AND DYEING METHOD USING SAME OREAL (FR) 2003-11-12 — — EP claimed
US-20030009835-A1 Oxidation dyeing composition for keratinous fibres and dyeing method using same L'OREAL S.A. (FR) 2003-01-16 — — US claimed
CN-1372458-A Oxidation dyeing composition for keratinous fibres and dyeing method using said composition OREAL (FR) 2002-10-02 — — CN claimed
US-6395042-B1 OXIDATION BASE, HETEROCYCLIC COUPLERS FOR OXIDATION COLOR DYE L'ORÉAL (FR) 2002-05-28 — — US claimed
EP-1181005-A1 OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES AND DYEING METHOD USING SAME L'OREAL (FR) 2002-02-27 — — EP claimed
WO-2001066071-A1 OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES AND DYEING METHOD USING SAME L'OREAL (FR) 2001-09-13 — — WO claimed
CN-1286615-A keratinous fibre oxidation dyeing composition contg. laccase and dyeing method using same OREAL (FR) 2001-03-07 — — CN claimed
WO-1998055083-A1 KERATIN FIBRE OXIDATION DYEING COMPOSITION AND DYEING METHOD USING SAME L'OREAL (FR) 1998-12-10 — — WO claimed
US-5785717-A Composition for the oxidation dyeing of keratin fibers, comprising a diaminopyrazole derivative and a heterocyclic coupler, and dyeing process L'OREAL (FR) 1998-07-28 — — US claimed
US-5769903-A Composition for the oxidation dyeing of keratin fibers, comprising an oxidation base, an indole coupler and an additional heterocyclic coupler, and dyeing process L'OREAL (FR) 1998-06-23 — — US claimed
EP-0728464-B1 Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process OREAL (FR) 1997-07-30 — — EP claimed
EP-0605320-B1 Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same OREAL (FR) 1997-04-09 — — EP claimed
CN-1137374-A Composition for oxidation dyeing of keratin fibers, comprising oxidation base, indole coupler and additional heterocyclic coupler, and dyeing process OREAL (FR) 1996-12-11 — — CN claimed
US-5578087-A Dyeing compositions for keratinous fibres based on para-phenylene-diamines, meta-phenylenediamine and benzimidazole derivatives, and dyeing process employing them L'OREAL (FR) 1996-11-26 — — US claimed
EP-0728466-A1 Keratinous fibers oxidation dyeing composition comprising an oxidation base, an indolic coupler and an additional heterocyclic coupler and dyeing process L'OREAL (FR) 1996-08-28 — — EP claimed
EP-0728464-A1 Composition for dyeing keratinous fibers comprising a diaminopyrazole derivative and a heterocyclic coupleur and dyeing process L'OREAL (FR) 1996-08-28 — — EP claimed
EP-0605320-A1 Dye composition for keratinic fibres based on paraphenylenediamine, metaphenylenediamines and benzimidazol derivates, and the dyeing process using same L'OREAL (FR) 1994-07-06 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030009835-A1 Oxidation dyeing composition for keratinous fibres and dyeing method using same KRT18, PPOX, NDUFB5 PARP1 1394/4885KDM4E 2568/4885CYP1A2 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback